SEARCH RESULTS FOR: "Tag: BLUE"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(5)
2017(12)
2016(11)
2015(21)
2014(2)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(2)
Analyst Update(10)
Analyst Upgrades(4)
Buzz Stocks(6)
Ezines(1)
General(7)
Intraday Option Activity(3)
Market Recap(1)
Midday Market Check(5)
Opening View(2)
Stock Market News(4)
Stocks On the Move(10)
Trade Postmortem(1)
Unusual Trading Activity(2)

8/6/2018 9:16 AM
Massachusetts-based biotech company bluebird bio (NASDAQ:BLUE) today announced a collaboration with Regeneron Pharmaceuticals (NASDAQ:REGN) to jointly develop new cell therapies for cancer. Under the...
6/15/2018 9:23 AM
Shares of bluebird bio Inc (NASDAQ:BLUE) are up 0.5% in electronic trading, after the company reported positive early stage trial data for its LentiGlobin gene therapy in patients with sickle cell di...
6/4/2018 9:53 AM
Biotech concern bluebird bio Inc (NASDAQ:BLUE) is higher in today's trading after the company reported data for its immunotherapy drug bb2121, which showed cancer patients survived for a median of r...
3/21/2018 9:42 AM
bluebird bio Inc (NASDAQ:BLUE) has been a major outperformer over the past year, but the stock has struggled since its March 13 record high of $236.17. In fact, BLUE shares have suffered six straight...
1/22/2018 3:31 PM
U.S. stock markets are back at record highs, after the Senate voted to pass a short-term funding bill, which will end the three-day government shutdown. Among individual stocks making big moves are c...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center